Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 6, 2011, Pages 1254-1260

  Pou, Jordi ^a   Rebollo, Alba ^a   Piera, Lídia ^a   Merlos, Manuel ^a   Roglans, Núria ^a,b   Laguna, Juan C ^a,b   Alegret, Marta ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Human macrophage; Lipoprotein; Thrombin; Tissue factor pathway inhibitor 2

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLACENTA PROTEIN 5; STRESS ACTIVATED PROTEIN KINASE; THROMBIN;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

AMINO ACID CHLOROMETHYL KETONES; ANTHRACENES; ANTITHROMBINS; BLOTTING, WESTERN; BUTADIENES; CELL LINE; CELLS, CULTURED; CYCLOOXYGENASE 2 INHIBITORS; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; GLYCOPROTEINS; HIRUDINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPROTEINS, VLDL; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRILES; NITROBENZENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; SIGNAL TRANSDUCTION; SULFONAMIDES; THROMBIN; TIME FACTORS;

EID: 79955665496     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.03.020     Document Type: Article

References (32)

1. Zawadzki C., Chatelain N., Delestre M., Susen S., Quesnel B., Juthier F., Jeanpierre E., Azzaoui R., Corseaux D., Breyne J., Torpier G., Staels B., Van B.E., Jude B. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 2009, 204:e4-e14.
2. Siegling S., Thyzel E., Glahn J., Kleesiek K., Gotting C. Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann. Hematol. 2006, 85:32-37.
3. Chand H.S., Foster D.C., Kisiel W. Structure, function and biology of tissue factor pathway inhibitor-2. Thromb. Haemost. 2005, 94:1122-1130.
4. Sierko E., Wojtukiewicz M.Z., Kisiel W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin. Thromb. Hemost. 2007, 33:653-659.
5. Petersen L.C., Sprecher C.A., Foster D.C. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996, 35:266-272.
6. Crawley J.T., Goulding D.A., Ferreira V., Severs N.J., Lupu F. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler. Thromb. Vasc. Biol. 2002, 22:218-224.
7. Higashikata T., Yamagishi M., Higashi T., Nagata I., Iihara K., Miyamoto S., Ishibashi-Ueda H., Nagaya N., Iwase T., Tomoike H., Sakamoto A. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 2006, 185:165-172.
8. Iino M., Foster D.C., Kisiel W. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler. Thromb. Vasc. Biol. 1998, 18:40-46.
9. Xu Z., Maiti D., Kisiel W., Duh E.J. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2819-2825.
10. Ekstrand J., Razuvaev A., Folkersen L., Roy J., Hedin U. Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. J. Vasc. Surg. 2010, 52:167-175.
11. Llaverias G., Pou J., Ros E., Zambon D., Cofan M., Sanchez A., Vazquez-Carrera M., Sanchez R.M., Laguna J.C., Alegret M. Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment. Pharmacogenomics 2008, 9:1035-1054.
12. Llaverias G., Jove M., Vazquez-Carrera M., Sanchez R.M., Diaz C., Hernandez G., Laguna J.C., Alegret M. Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages. Eur. J. Pharmacol. 2002, 451:11-17.
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
14. Kang K.W., Choi S.Y., Cho M.K., Lee C.H., Kim S.G. Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation. J. Biol. Chem. 2003, 278:17368-17378.
15. Zheng L., Martins-Green M. Molecular mechanisms of thrombin-induced interleukin-8 (IL-8/CXCL8) expression in THP-1-derived and primary human macrophages. J. Leukoc. Biol. 2007, 82:619-629.
16. Venkatesan S., Cullen P., Pacy P., Halliday D., Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb. 1993, 13:1110-1118.
17. Neaud V., Duplantier J.G., Mazzocco C., Kisiel W., Rosenbaum J. Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism. J. Biol. Chem. 2004, 279:5200-5206.
18. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J. Biol. Chem. 1998, 273:1288-1297.
19. Fanjul A., Dawson M.I., Hobbs P.D., Jong L., Cameron J.F., Harlev E., Graupner G., Lu X.P., Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 1994, 372:107-111.
20. Ter A.E., Holewijn S., Bredie S.J., Stalenhoef A.F., de Graaf J. Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia. Atherosclerosis 2007, 191:220-226.
21. Georgieva A.M., Cate H.T., Keulen E.T., Van O.R., Govers-Riemslag J.W., Hamulyak K., van der Kallen C.J., Van Greevenbroek M.M., De Bruin T.W. Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome. Atherosclerosis 2004, 175:345-351.
22. Croce K., Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr. Opin. Hematol. 2007, 14:55-61.
23. Xue M., Hollenberg M.D., Yong V.W. Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J. Neurosci. 2006, 26:10281-10291.
24. Lo H.M., Chen C.L., Tsai Y.J., Wu P.H., Wu W.B. Thrombin induces cyclooxygenase-2 expression and prostaglandin E2 release via PAR1 activation and ERK1/2- and p38 MAPK-dependent pathway in murine macrophages. J. Cell. Biochem. 2009, 108:1143-1152.
25. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
26. Hube F., Reverdiau P., Iochmann S., Cherpi-Antar C., Gruel Y. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb. Res. 2003, 109:207-215.
27. Karin M., Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9067-9069.
28. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 2002, 23:144-150.
29. Nasrallah R., Laneuville O., Ferguson S., Hebert R.L. Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. Am. J. Physiol. Renal Physiol. 2001, 281:F123-F132.
30. Butzow R., Lehto V.P., Ritvos O., Ranta T., Seppala M. Regulation of the production of placental protein 5 by human endometrial stromal cells; the role of prostaglandins E2 and F2 alpha. Mol. Cell. Endocrinol. 1988, 60:137-143.
31. Martorell L., Martinez-Gonzalez J., Crespo J., Calvayrac O., Badimon L. Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth. J. Thromb. Haemost. 2007, 5:1766-1773.
32. Pan J.J., Shi H.M., Luo X.P., Ma D., Li Y., Zhu J., Liang W., Mu J.G., Li J. Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL. Eur. J. Pharmacol. 2011, 654:135-141.